documents: FDA-2004-N-0191-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2004-N-0191-0002 | FDA | FDA-2004-N-0191 | Definition of Primary Mode of Action of a Combination Product | Proposed Rule | Extension of Comment Period | 2004-06-25T04:00:00Z | 2004 | 6 | 2004-06-24T04:00:00Z | 2004-08-21T03:59:59Z | 2025-04-22T11:40:20Z | 04-14265 | 0 | 0 | 0900006480470985 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref